Product
Akynzeo
1 clinical trial
1 indication
Indication
Chemotherapy-Induced Nausea and VomitingClinical trial
Akynzeo or Olanzapine for Patients Who Experience Breakthrough CINV in Patient Receiving Moderately or Highly Emetogenic Chemotherapy After First Cycle of ChemotherapyStatus: Recruiting, Estimated PCD: 2023-12-31